- Home
- BHAT vs LPCN Comparison
BHAT vs LPCN Comparison
Compare BHAT & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- LPCN
- Stock Information
- Founded
- BHAT 2010
- LPCN 1997
- Country
- BHAT China
- LPCN United States
- Employees
- BHAT N/A
- LPCN N/A
- Industry
- BHAT Recreational Games/Products/Toys
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- LPCN Health Care
- Exchange
- BHAT Nasdaq
- LPCN Nasdaq
- Market Cap
- BHAT 18.2M
- LPCN 16.4M
- IPO Year
- BHAT 2019
- LPCN N/A
- Fundamental
- Price
- BHAT $1.86
- LPCN $3.24
- Analyst Decision
- BHAT
- LPCN Strong Buy
- Analyst Count
- BHAT 0
- LPCN 1
- Target Price
- BHAT N/A
- LPCN $10.00
- AVG Volume (30 Days)
- BHAT 1.7M
- LPCN 10.5K
- Earning Date
- BHAT 04-29-2025
- LPCN 03-13-2025
- Dividend Yield
- BHAT N/A
- LPCN N/A
- EPS Growth
- BHAT N/A
- LPCN N/A
- EPS
- BHAT N/A
- LPCN N/A
- Revenue
- BHAT $40,461,026.00
- LPCN $11,198,144.00
- Revenue This Year
- BHAT N/A
- LPCN N/A
- Revenue Next Year
- BHAT N/A
- LPCN $37.31
- P/E Ratio
- BHAT N/A
- LPCN N/A
- Revenue Growth
- BHAT N/A
- LPCN N/A
- 52 Week Low
- BHAT $1.65
- LPCN $2.91
- 52 Week High
- BHAT $145.00
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- BHAT 38.04
- LPCN 41.52
- Support Level
- BHAT $1.65
- LPCN $3.00
- Resistance Level
- BHAT $2.20
- LPCN $3.57
- Average True Range (ATR)
- BHAT 0.51
- LPCN 0.24
- MACD
- BHAT 0.08
- LPCN -0.00
- Stochastic Oscillator
- BHAT 18.56
- LPCN 23.29
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.